On January 28, Baxter announced that it has resumed IV solutions production across all manufacturing lines at its North Carolina facility, which was affected by Hurricane Helene in October.
While some lines will need additional time to ramp up, the company anticipates that production will reach pre-hurricane levels by early Q1 2025.